Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.
You can purchase shares of Intra-Cellular Therapies (NASDAQ:ITCI) through any online brokerage.
Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).
Intra-Cellular Therapies has a consensus price target of $94.40.
The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $85.67 last updated November 21, 2024 at 1:25 PM EST.
There are no upcoming dividends for Intra-Cellular Therapies.
Intra-Cellular Therapies’s Q4 earnings are confirmed for Thursday, February 20, 2025.
There is no upcoming split for Intra-Cellular Therapies.
Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.